NPI: 1861009672 · HEALDSBURG, CA 95448 · General Acute Care Hospital · NPI assigned 09/25/2020
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| NPI Enumeration Date | 09/25/2020 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2022 | 7,554 | $684K |
| 2023 | 24,815 | $2.22M |
| 2024 | 17,223 | $1.67M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 8,743 | 7,677 | $1.70M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 6,146 | 5,020 | $580K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,323 | 1,848 | $380K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,892 | 1,048 | $344K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 861 | 801 | $168K |
| 97750 | 1,114 | 571 | $166K | |
| 93976 | 115 | 114 | $98K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 972 | 897 | $89K |
| 96375 | Therapeutic injection; each additional sequential IV push | 688 | 639 | $87K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 247 | 243 | $87K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 858 | 823 | $78K |
| 96361 | Intravenous infusion, hydration; each additional hour | 793 | 720 | $72K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 876 | 830 | $71K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 63 | 63 | $50K |
| 70450 | Computed tomography, head or brain; without contrast material | 101 | 96 | $44K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 171 | 162 | $43K |
| 71045 | Radiologic examination, chest; single view | 763 | 721 | $30K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 78 | 77 | $29K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 29 | 24 | $29K |
| 73562 | 341 | 313 | $29K | |
| J3490 | Unclassified drugs | 3,933 | 2,504 | $26K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 105 | 104 | $24K |
| 80053 | Comprehensive metabolic panel | 2,137 | 1,934 | $20K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 557 | 525 | $17K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 86 | 80 | $17K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 134 | 128 | $17K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 64 | 61 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2,334 | 2,098 | $16K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 384 | 326 | $16K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 72 | 70 | $14K |
| 71046 | Radiologic examination, chest; 2 views | 223 | 214 | $14K |
| Q3014 | Telehealth originating site facility fee | 140 | 127 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 327 | 299 | $13K |
| Z7502 | 345 | 330 | $13K | |
| 99070 | 837 | 413 | $12K | |
| 73110 | 126 | 111 | $12K | |
| 73030 | 117 | 104 | $11K | |
| 81001 | 1,095 | 1,027 | $10K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 128 | 126 | $10K |
| 73130 | 96 | 87 | $9K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 201 | 195 | $9K |
| 84484 | 707 | 581 | $7K | |
| 83690 | 999 | 933 | $6K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 190 | 179 | $6K |
| 76830 | Ultrasound, transvaginal | 25 | 25 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 998 | 936 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 109 | 102 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 67 | 62 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | 614 | 564 | $5K |
| 73610 | 44 | 43 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 833 | 760 | $4K |
| 73630 | 44 | 38 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 147 | 143 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 29 | 28 | $3K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 12 | 12 | $2K |
| 76801 | 12 | 12 | $2K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 58 | 52 | $2K |
| J2704 | Injection, propofol, 10 mg | 250 | 235 | $2K |
| 81025 | 577 | 555 | $2K | |
| 0450 | Emergency room services | 33 | 31 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 240 | 226 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 175 | 162 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 179 | 174 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 131 | 123 | $915.67 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 127 | 116 | $851.36 |
| 83880 | 32 | 31 | $771.84 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 25 | 25 | $748.08 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 160 | 156 | $728.81 |
| 73140 | 12 | 12 | $708.48 | |
| 80305 | 68 | 62 | $680.96 | |
| 81003 | 319 | 295 | $611.25 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 61 | 55 | $606.48 |
| 82150 | 112 | 109 | $590.54 | |
| 90715 | 12 | 12 | $513.24 | |
| 83605 | 46 | 41 | $421.57 | |
| 82962 | 161 | 103 | $381.28 | |
| J7050 | Infusion, normal saline solution, 250 cc | 62 | 52 | $305.89 |
| 87077 | 42 | 38 | $261.26 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 16 | 15 | $211.75 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 12 | 12 | $208.46 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 36 | 26 | $199.65 |
| 96127 | 15 | 15 | $188.31 | |
| 87040 | 23 | 12 | $172.32 | |
| Z7610 | 21 | 12 | $157.89 | |
| 87070 | 15 | 12 | $151.31 | |
| 85610 | 44 | 40 | $141.79 | |
| J2060 | Injection, lorazepam, 2 mg | 26 | 25 | $140.70 |
| 87081 | 17 | 13 | $96.56 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 12 | 12 | $90.53 |
| 87205 | 15 | 12 | $70.01 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 13 | 12 | $11.88 |